Belkyra™ is an injectable medication approved for the treatment and reduction of excess fat under the chin (chin fat) on the upper neck, a condition that is commonly referred to as a “double chin” or sometimes even a “triple chin.” 

This is the first medication for double chin of its kind that has been approved by Health Canada. The FDA also approved this medication in the United States where it known as Kybella™.  Kybella was released in the USA before Belkyra was allowed in Canada. 

The treatment is non-surgical and non-invasive, and consists of a series of injections of deoxycholic acid, which is a naturally occurring molecule in the body that helps break down fat. When injected into fat cells, it leads to destruction of fat cells. In our Edmonton clinic, Belkyra injections have been very effective and have made many patients very happy with their outcomes.